NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease.
about
A Unified Hypothesis of Early- and Late-Onset Alzheimer's Disease PathogenesisNeurodegenerative disease and adult neurogenesisProstaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotectionAberrant cell cycle reentry in human and experimental inclusion body myositis and polymyositisPathological implications of cell cycle re-entry in Alzheimer disease.Reimagining Alzheimer's disease--an age-based hypothesis.Regulation of tau pathology by the microglial fractalkine receptor.Glutamine acts as a neuroprotectant against DNA damage, beta-amyloid and H2O2-induced stress.ATM and the epigenetics of the neuronal genome.DNA damage and cell cycle events implicate cerebellar dentate nucleus neurons as targets of Alzheimer's disease.Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer's diseaseNonsteroidal anti-inflammatory drug naproxen destabilizes Aβ amyloid fibrils: a molecular dynamics investigation.Multi-target action of the novel anti-Alzheimer compound CHF5074: in vivo study of long term treatment in Tg2576 mice.Binding of nonsteroidal anti-inflammatory drugs to Abeta fibrilNeurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease.Naproxen interferes with the assembly of Aβ oligomers implicated in Alzheimer's disease.Drug development for Alzheimer's disease: recent progressAlzheimer's Disease: Fatty Acids We Eat may be Linked to a Specific Protection via Low-dose Aspirin.Non-Neuronal Cells Are Required to Mediate the Effects of Neuroinflammation: Results from a Neuron-Enriched Culture System.Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE-1 in a transgenic model of Alzheimer's disease-like amyloid pathology.Quantitating the subtleties of microglial morphology with fractal analysis.Panel of Genetic Variations as a Potential Non-invasive Biomarker for Early Diagnosis of Alzheimer's Disease.Identification and modification of amyloid-independent phenotypes of APOE4 miceMicroglial derived tumor necrosis factor-α drives Alzheimer's disease-related neuronal cell cycle eventsUntangling the Web: Toxic and Protective Effects of Neuroinflammation and PGE2 Signaling in Alzheimer's Disease.Therapeutic implications of the prostaglandin pathway in Alzheimer's disease.Beyond amyloid: getting real about nonamyloid targets in Alzheimer's disease.Mechanisms of action of non-steroidal anti-inflammatory drugs for the prevention of Alzheimer's disease.Neuroinflammatory processes in Alzheimer's disease.Therapeutic intervention for Alzheimer's disease with γ-secretase inhibitors: still a viable option?NSAIDs in the treatment and/or prevention of neurological disorders.The role of clusterin in Alzheimer's disease: pathways, pathogenesis, and therapy.Review: experimental manipulations of microglia in mouse models of Alzheimer's pathology: activation reduces amyloid but hastens tau pathology.Neuroinflammation in the pathogenesis of Alzheimer's disease. A rational framework for the search of novel therapeutic approaches.A comparative study of five mouse models of Alzheimer's disease: cell cycle events reveal new insights into neurons at risk for deathAdult neurogenesis in neurodegenerative diseases.The Role of PGRN in Alzheimer's Disease.Potential Use of Flavopiridol in Treatment of Chronic Diseases.Role of Microglia in Neurological Disorders and Their Potentials as a Therapeutic Target.Re-imagining Alzheimer's disease - the diminishing importance of amyloid and a glimpse of what lies ahead.
P2860
Q26781496-95B29CC2-055C-454C-B112-78363208CCD3Q28307113-F4D627D7-6C47-41A0-BE60-C3D30346CA88Q33651797-20CAB5B5-7F50-48B1-A5F4-38FD82D8EDA5Q33784450-96B2D01C-6D28-47A4-AF0D-A902F02A1303Q34070765-3AFA801A-8164-4516-B35E-F00EEE844D40Q34155080-EB8DB3A9-9C79-47AE-B346-2A3B67516744Q34179654-0E227BC9-D9F8-4C36-8540-439127CDA10DQ34193698-F4976061-C42B-4E32-9D3D-9E45DB65105FQ34346685-FAECC3BD-070A-4751-988A-B0A193841DCCQ34477972-571A967B-5554-496B-8751-354E6162F1BDQ34499359-7FE7DBB9-022D-4942-9C4A-79910CD857E7Q34555178-CD151138-DE4A-4300-87F1-AEFC0F6809EBQ34656871-A4F2E348-C959-48A3-A41B-C986AB163528Q34680971-3E372F9F-7089-4255-9098-8E55276A2805Q34774194-3909FAAF-278C-44C3-B278-808B26AB4546Q34800804-9E0099AB-0C22-47CE-9452-DFBA1666DAE0Q35545974-B2D7352E-8246-43D6-A534-2868012B0CD4Q35806684-7CBFA1C0-EC69-4349-ACDC-08C759C3BE6CQ35898735-7D1AB144-1498-4721-9944-483C6CE28CAFQ35959633-6B631FDA-F55A-47DB-B557-56FF6C22B4CEQ36572876-2B81FFA8-2235-470E-86E4-CDED2A122372Q36600561-749310A9-F384-49C2-891B-FBE0B41DCA9FQ36880457-1730D144-CBDC-42A0-AF7A-05BAB121F857Q37424545-AAFEFF03-3DEF-4B7F-B8DA-15EADB94FAEFQ37588183-D3FA8CAB-1786-41D6-9DB5-CA4FC6267ED7Q37678539-D1C2BEF3-BF87-43C2-935E-AE68099D4ED6Q37697772-5EA858C8-AD99-4C4B-A419-0BA5C83D4B8CQ37703299-A115CFF3-ADA9-448E-A300-C6C56166E097Q37772809-7A413078-5057-4A04-8FA4-8B06DE230EF1Q37827490-A81A762C-E36B-4E0D-9F5B-F24B0E20A231Q37974560-44A16098-7A2D-4F35-9299-647CD01D57B0Q37978548-1D4F0779-CD13-49AF-9193-114CC4B0BF48Q38061480-6EC399DF-5270-4BC5-AAA7-AE95ABBF3AD9Q38209311-9CF80B48-B56B-41E1-A15C-2BE05E7D8C6AQ38368071-7D2E1DD2-3E7B-44A5-8296-3739851CF5B7Q38400868-D5079774-ADA3-47B2-B3E1-5C6DF65658C4Q38555411-11FD1951-7A07-4A1D-A179-CDE131FB6033Q38988581-1B7E981D-8FB7-42FD-A6D0-500B6321CE52Q39004244-E5FD498D-1AF9-49B1-BE54-A1374AAE9D49Q39332179-31D9A3F8-35D8-4B39-BF13-CD8CEA53208F
P2860
NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
NSAIDs prevent, but do not rev ...... se model of Alzheimer disease.
@en
NSAIDs prevent, but do not rev ...... se model of Alzheimer disease.
@nl
type
label
NSAIDs prevent, but do not rev ...... se model of Alzheimer disease.
@en
NSAIDs prevent, but do not rev ...... se model of Alzheimer disease.
@nl
prefLabel
NSAIDs prevent, but do not rev ...... se model of Alzheimer disease.
@en
NSAIDs prevent, but do not rev ...... se model of Alzheimer disease.
@nl
P2093
P2860
P356
P1476
NSAIDs prevent, but do not rev ...... use model of Alzheimer disease
@en
P2093
Bruce T Lamb
Karl Herrup
Kiran Bhaskar
Maria Z Kounnas
Steven L Wagner
P2860
P304
P356
10.1172/JCI39716
P407
P577
2009-11-09T00:00:00Z